Upstream Bio, Inc. (UPB) Financials
UPB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 318.1 million | 14.1 million |
| Dec. 31, 2025 | 353.8 million | 14.0 million |
| Sept. 30, 2025 | 391.2 million | 12.6 million |
| June 30, 2025 | 420.5 million | 11.8 million |
UPB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -47.9 million | 4.6 million |
| Dec. 31, 2025 | -30.7 million | 2.5 million |
| Sept. 30, 2025 | -22.2 million | 2.6 million |
| June 30, 2025 | -39.3 million | 2.6 million |
UPB Net Income
No data available :(
UPB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 294.6 million | 390000 | - |
| Dec. 31, 2025 | 341.5 million | 549000 | - |
| Sept. 30, 2025 | 372.4 million | 703000 | - |
| June 30, 2025 | 393.6 million | 849000 | 1.6 million |
UPB Shares Outstanding
UPB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 36.6 million | 8.1 million | - |
| Dec. 31, 2025 | 47000 | 40.2 million | 6.7 million | - |
| Sept. 30, 2025 | 47000 | 33.0 million | 5.5 million | - |
| June 30, 2025 | 47000 | 37.9 million | 7.4 million | - |
UPB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 1.0 million | 49000 |
| Dec. 31, 2025 | 668000 | 57000 |
| Sept. 30, 2025 | 683000 | 31000 |
| June 30, 2025 | 937000 | 57000 |
UPB
Price: $5.92
52 week price:
Earnings Per Share: -6.31 USD
P/E Ratio: -1.22
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 383.7 million